Elevated 68 Ga-FAPI Activity in Tailgut Cyst Adenocarcinoma.

IF 9.6 3区医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Clinical Nuclear Medicine Pub Date : 2024-11-01 Epub Date: 2024-08-27 DOI:10.1097/RLU.0000000000005413

Yilin Huang, Lei Ou, Chengrun Zeng, Xiaoliang Chen

引用次数: 0

Abstract

Abstract: Tailgut cyst adenocarcinoma is a rare malignant tumor. We present 68 Ga-FAPI PET/CT findings of tailgut cyst adenocarcinoma in a 46-year-old woman. Tailgut cyst adenocarcinoma on 68 Ga-FAPI PET/CT showed increased tracer uptake. This case demonstrates the potential value of 68 Ga-FAPI PET/CT for evaluating tailgut cyst adenocarcinoma.

查看原文本刊更多论文

尾状囊腺癌的 68Ga-FAPI 活性升高

摘要：尾肠囊腺癌是一种罕见的恶性肿瘤。我们介绍了一名 46 岁女性尾状腺囊腺癌的 68Ga-FAPI PET/CT 检查结果。尾状腺囊肿腺癌在 68Ga-FAPI PET/CT 上显示示踪剂摄取增加。本病例显示了 68Ga-FAPI PET/CT 在评估尾肠囊肿腺癌方面的潜在价值。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Nuclear Medicine 医学-核医学

CiteScore

2.90

自引率

31.10%

发文量

1113

审稿时长

2 months

期刊介绍： Clinical Nuclear Medicine is a comprehensive and current resource for professionals in the field of nuclear medicine. It caters to both generalists and specialists, offering valuable insights on how to effectively apply nuclear medicine techniques in various clinical scenarios. With a focus on timely dissemination of information, this journal covers the latest developments that impact all aspects of the specialty. Geared towards practitioners, Clinical Nuclear Medicine is the ultimate practice-oriented publication in the field of nuclear imaging. Its informative articles are complemented by numerous illustrations that demonstrate how physicians can seamlessly integrate the knowledge gained into their everyday practice.